Literature DB >> 15363552

What are the oncological risks of minimal access surgery for the treatment of urinary tract cancer?

Grant D Stewart1, David A Tolley.   

Abstract

OBJECTIVES: A review of the oncological safety of minimal access surgery for the treatment of urinary tract cancers. The particular areas reviewed were port-site metastases, local tumour recurrence and long-term survival.
METHODS: Review of the literature using Medline.
RESULTS: There is a low rate of port-site metastases following laparoscopic surgery for urological malignancies, these are usually related to the stage and grade of the tumour. So far follow-up data shows that laparoscopic surgery for urological malignancy does not result in higher levels of local recurrence or shorter survival than open surgery. Percutaneous (PCN) and ureteroscopic (URS) resection of TCC of the upper urinary tract are acceptable forms of treatment for grade 1 and 2 TCCs even in patients with normal contralateral kidneys. However, for grade 3 TCC nephroureterectomy should be utilised because of increased risk of local recurrence (URS) and track seeding (PCN).
CONCLUSIONS: Provided the principles of cancer surgery, combined with proper case selection are followed, minimal access surgery for urological cancer is safe and is rapidly emerging as the standard of care for many upper tract tumours.

Entities:  

Mesh:

Year:  2004        PMID: 15363552     DOI: 10.1016/j.eururo.2004.04.030

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  5 in total

1.  Port site and peritoneal metastases after robot-assisted radical prostatectomy.

Authors:  Omer Acar; Tarık Esen; Sevil Bavbek; Onder Peker; Ahmet Musaoğlu
Journal:  Int J Surg Case Rep       Date:  2014-01-24

2.  Port-site metastasis after laparoscopic surgery for urological malignancy: forgotten or missed.

Authors:  N Kadi; M Isherwood; M Al-Akraa; S Williams
Journal:  Adv Urol       Date:  2012-04-10

3.  Does preoperative percutaneous nephrostomy insertion worsen upper-tract urothelial cancer oncological outcome? A retrospective single center study.

Authors:  Guan-Lin Huang; Hao-Lun Luo; Po-Hui Chiang
Journal:  BMC Urol       Date:  2019-06-07       Impact factor: 2.264

4.  Is port site metastasis a result of systemic involvement?

Authors:  Samit Chaturvedi; Vikas Bansal; Rakesh Kapoor; Anil Mandhani
Journal:  Indian J Urol       Date:  2012-04

5.  Port-site metastasis as a primary complication following retroperitoneal laparoscopic radical resection of renal pelvis carcinoma or nephron-sparing surgery: A report of three cases and review of the literature.

Authors:  Ning Wang; Kai Wang; Dachuan Zhong; Xia Liu; J I Sun; Lianxiang Lin; Linna Ge; B O Yang
Journal:  Oncol Lett       Date:  2016-05-06       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.